FNDC5 and early-onset autosomal dominant Alzheimer disease: In models of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), irisin levels are typically lower, and exogenous administration of irisin has been shown to significantly reduce oxidative stress levels in the brain and enhance mitochondrial function [33, 34].